People · Operator
Named in public records as an officer, director or promoter · active 2014–2024 · Pharma, Other
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Time Therapeutics Inc. | — | Pharma | Series A | $28.6M | $66.9M | 2018 |
| Citelighter, Inc. | — | Other | Seed | $3.7M | $8.9M | 2014 |
Mohammad Saad Alam at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Mohammad Saad Alam on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Stuart Blitz | 1 | 2 |
| John Lee Cammack | 1 | 1 |
| Kevin Lee Hollins | 1 | 1 |
| Alessandro Lee Piol | 1 | 1 |
| Mohammed Saad Alam | 1 | 1 |
| Theodore Maidenberg | 1 | 1 |
| John Saad Cammack | 1 | 1 |
| Robert Lee Jokl III | 1 | 1 |
| Robert Lee Jokl | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.